Search Results 1-10 of 27926 for %EC%88%98%EB%8F%99%EB%B0%94%EB%94%94%ED%94%84%EB%9E%9C%EB%93%9C%EC%95%88%EB%A7%88%EC%9D%98%EC%9E%90/%EC%BD%94%EC%B2%B4/%EC%82%AC%ED%8C%8C%EB%A8%B8%EC%8B%A0/%EC%BD%94%EC%A7%80%EB%A7%88/%ED%98%84%EB%8C%80%EC%84%BC%EC%95%88%EB%A7%88/%EC%97%98%EC%A7%80%E3%80%90KaKaotalk:za32%E3%80%91%EC%84%9C%EC%9A%B8%EC%B6%9C%EC%9E%A5%EC%95%88%EB%A7%88,%EC%84%9C%EC%9A%B8%EC%97%90%EC%8A%A4%ED%94%8C%EB%9F%AC%EC%8A%A4,%EC%84%9C%EC%9A%B8%EC%B6%9C%EC%9E%A5%EC%97%85%EC%86%8C,%EC%84%9C%EC%9A%B8%ED%99%8D%EB%93%B1%EA%B0%80,%EC%84%9C%EC%9A%B8%EC%BD%9C%EA%B1%B8
Division of Hematology.
Macitentan in Pulmonary.
Rare Kidney Stone Consortium.
99%. 26. 93%. Ph sician Assistant. •. •. • 1 □ • 1 1 ... 88%. 8. 100%. Medical Laboratorv Scientist. 24. 24. 25 ... 94%. Positron Emission Tomoaraohv. 3. 2. 3. 100 ...
:# Test. Takers. 88. %. 100. %. 100 %. 96. %. # earners: 1. 1. :# Test. Takers. # earners: 0. 0. :# Test. Takers. # earners: 2. 2. :# Test. Takers. 100 %. #DIV/ ...
Jeans EB, Breen WG, Mullikin TC, Looker BA, Mariani A, Keeney GL, Haddock MG, Petersen IA. Adjuvant brachytherapy for FIGO stage I serous or clear cell ...
Harmeet Malhi, M.B.B.S.. Transplant Hepatologist. Wong CC, Tapper EB, Malhi H, Gores GJ. Manuscript best practices: Takeaways from a community conversation.
About this study. This is a randomized, open label, adaptive platform trial to compare the effectiveness of antithrombotic strategies for prevention of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.